Brief: Prophase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Plans Significant Cost-Cutting Measures
Dec 11 (Reuters) - Prophase Labs PRPH.O :
* PROPHASE LABS: SECURES GLOBAL PRIVATE EQUITY BACKING,
NEARS
MAJOR LOZENGE DEAL, PLANS SIGNIFICANT COST-CUTTING MEASURES
* PROPHASE LABS: JAY SCHWARTZ WILL ASSIST CO IN PURSUING
STRATEGIC ALTERNATIVES INCLUDING A POTENTIAL SALE OF PHARMALOZ
* PROPHASE LABS: FINALIZING COST-SAVING MEASURES TARGETING
NON-CORE OPERATIONS THAT WILL REDUCE OPERATING EXPENSES BY AT
LEAST $6 MILLION/YEAR
Source text: ID:nGNX9zCrNg
Further company coverage: PRPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prophase Labs
See all newsBrief: Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:29 PM